A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer.
Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer-related death worldwide, and the 5-year survival rate is still low despite advances in diagnosis and therapeutics. A long noncoding RNA (lncRNA) HOX antisense intergenic RNA (HOTAIR) has been revealed to play important roles in NSCLC carcinogenesis but the detailed mechanisms are still unclear. In the current study, we aimed to investigate the regulation between the lncRNA HOTAIR and p53 in the NSCLC patient samples and cell lines. Our results showed that HOTAIR expression was significantly higher in the cancer tissues than that in the adjacent normal tissue, and was negatively correlated with p53 functionality rather than expression. When p53 was overexpressed in A549 cells, the lncRNA HOTAIR expression was downregulated, and the cell proliferation rate and cell invasion capacity decreased as a consequence. We identified two binding sites of p53 on the promoter region of HOTAIR, where the p53 protein would bind to and suppress the HOTAIR mRNA transcription. Inversely, overexpression of lncRNA HOTAIR inhibited the expression of p53 in A549 cells. Mechanistic studies revealed that HOTAIR modified the promoter of p53 and enhanced histone H3 lysine 27 trimethylation (H3K27me3). These studies identified a specific negative regulation loop of lncRNA HOTAIR and p53 in NSCLC cells, which revealed a new understanding of tumorigenesis in p53 dysfunction NSCLC cells.
Department of Respiratory Medicine, Affiliated Hospital of Binzhou Medical University.
Nailiang
N
Zhai
Department of Respiratory Medicine, Affiliated Hospital of Binzhou Medical University.
Yongfu
Y
Xia
Department of Respiratory Medicine, People's Hospital of Binzhou City.
Rui
R
Yin
Department of Pharmacology, Binzhou Medical University, Binzhou, Shandong, People's Republic of China.
Jinping
J
Liu
Department of Respiratory Medicine, Affiliated Hospital of Binzhou Medical University.
Fuquan
F
Gao
LncRNA HOTAIR; NSCLC; negative loop; p53
Clin Chim Acta. 2014 Apr 20;431:255-9
24583225
CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41
22700443
J Biomed Biotechnol. 2011;2011:583929
21331359
PLoS One. 2014 Aug 04;9(8):e104044
25089627
Nature. 2009 Jan 22;457(7228):413-20
19158787
PLoS One. 2013 Dec 18;8(12 ):e84659
24367688
Cell Death Dis. 2015 Oct 15;6:e1907
26469956
J Hematol Oncol. 2013 May 31;6:37
23725405
Jpn J Clin Oncol. 2012 Oct;42(10):985
23002450
Cell. 1997 Feb 7;88(3):323-31
9039259
Cancer Res. 2011 Oct 15;71(20):6320-6
21862635
J Int Med Res. 2011;39(6):2119-28
22289527
Lung Cancer. 2014 Aug;85(2):110-5
24906504
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72
19571010
Oncol Rep. 2014 Dec;32(6):2517-26
25333671
EMBO Rep. 2001 Nov;2(11):986-91
11713189
Biochim Biophys Acta. 2015 Aug;1856(1):151-64
26208723
Clin Chest Med. 2011 Dec;32(4):605-44
22054876
Curr Opin Cell Biol. 2009 Jun;21(3):416-25
19447594
N Engl J Med. 2014 Nov 20;371(21):1963-71
25264305
Oncogene. 2003 Dec 8;22(56):9030-40
14663481
Cancer Discov. 2011 Oct;1(5):391-407
22096659
Mol Med. 1997 Jul;3(7):441-51
9260156
Acta Biochim Biophys Sin (Shanghai). 2014 Jan;46(1):1-5
24165275
Med Oncol. 2014 Sep;31(9):137
25085781
Carcinogenesis. 2014 Jul;35(7):1510-5
24583926
Genome Biol. 2014 Aug 13;15(8):429
25116943
Oncogene. 2013 Mar 28;32(13):1616-25
22614017
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
21685461
N Engl J Med. 2009 Sep 3;361(10):947-57
19692680
Biochem Biophys Res Commun. 2013 Jun 28;436(2):319-24
23743197
Cancer Res. 2005 May 15;65(10):3980-5
15899785
Ann Oncol. 2013 Jan;24(1):20-30
23180113
Cell. 2007 Jun 29;129(7):1311-23
17604720
Nature. 2010 Apr 15;464(7291):1071-6
20393566
Oncogene. 2010 Jul 29;29(30):4245-52
20498645